What is the optimal dose of adipose-derived mesenchymal stem cells treatment for knee osteoarthritis? A conventional and network meta-analysis of randomized controlled trials
Abstract Background Despite increasing clinical investigations underscoring the efficacy and safety of adipose-derived mesenchymal stem cells (AD-MSCs) therapy in knee osteoarthritis (KOA), no article has recently reviewed the cell dosage. This study aimed to evaluate the efficacy and safety of vary...
Main Authors: | Zongyuan Huang, Shuai Zhang, Mingde Cao, Zhujian Lin, Ling Kong, Xin Wu, Qianshi Guo, Yuxiang Ouyang, Yancheng Song |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-023-03475-5 |
Similar Items
-
Intra-Articular Mesenchymal Stem Cell Injection for Knee Osteoarthritis: Mechanisms and Clinical Evidence
by: Pengxu Wei, et al.
Published: (2022-12-01) -
Efficacy of mesenchymal stromal cells for the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials
by: Huazheng Qu, et al.
Published: (2021-01-01) -
POSSIBILITIES OF USING ADIPOSE TISSUE-DERIVED STEM CELLS IN DEFORMING OSTEOARTHRITIS OF THE KNEE JOINT
by: Fishchenko V. O., et al.
Published: (2022-03-01) -
Knee Osteoarthritis: Epidemiology, Pathogenesis, and Mesenchymal Stem Cells: What Else Is New? An Update
by: Riccardo Giorgino, et al.
Published: (2023-03-01) -
Intra-articular injection of bone marrow aspirate concentrate (BMAC) or adipose-derived stem cells (ADSCs) for knee osteoarthritis: a prospective comparative clinical trial
by: Andrea Pintore, et al.
Published: (2023-05-01)